New PMPRB rules could impact patients with rare diseases: study
The federal government’s plan to increasingly regulate pharmaceutical costs could mean Canadians with rare diseases may lose access to new innovative drug treatments, according to a new…
- By: Staff
- August 30, 2018 September 13, 2019
- 10:08











